Propanc Biopharma, Inc. Business Finance Contracts & Agreements

245 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement dated February 7, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement dated January 31, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Convertible Promissory Note dated February 7, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Convertible Promissory Note dated January 31, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement dated December 4, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement dated December 15, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated December 4, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Convertible Promissory Note dated December 15, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Loan Agreement with Aggro Investments Pty Ltd dated December 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Securities Purchase Agreement dated September 20, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated September 20, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated August 2, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated August 2, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Loan Agreement dated June 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Securities Purchase Agreement dated June 20, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Convertible Promissory Note dated June 20, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Securities Purchase Agreement dated June 10, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Convertible Promissory Note dated June 10, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Loan Agreement dated June 5, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Loan Agreement dated June 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Loan Agreement dated June 5, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Loan Agreement dated June 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Securities Purchase Agreement dated May 22, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Convertible Promissory Note dated May 22, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement dated April 12, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated April 12, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated March 1, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Convertible Promissory Note dated March 1, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Securities Purchase Agreement dated December 8, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Convertible Promissory Note dated December 8, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement dated November 29, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Convertible Promissory Note dated November 29, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated as of October 20, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
8% Convertible Promissory Note, dated October 20, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated as of October 12, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
8% Convertible Redeemable Note, dated October 12, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement, dated as of August 23, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
8% Convertible Redeemable Note, dated August 23, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement, dated as of August 16, 2023, by and between the Company and the August Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
8% Convertible Promissory Note, dated August 16, 2023, issued to the August Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023